Effects of an inhibitor of topoisomerase II, ICRF-193 on the formation of ultraviolet-induced chromosomal aberrations

被引：15
|
作者：
Ikushima, T
Shima, Y
Ishii, Y
机构：
[1] Kyoto Univ Educ, Div Biol, Fushimi Ku, Kyoto 6120863, Japan
[2] Osaka Univ, Fac Med, Dept Radiat Biol, Osaka 5650871, Japan
来源：
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS | 1998年 / 404卷 / 1-2期
关键词：
Chinese hamster cell; topoisomerase II inhibitor; ICRF-193; chromosomal aberration; UV;
D O I：
10.1016/S0027-5107(98)00092-X
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Treatments of Chinese hamster V79 cells during one cell cycle with a new type of topoisomerase II inhibitor, ICRF-193, which does not accumulate cleavable topoisomerase-DNA complexes induced both chromosome- and chromatid-type aberrations with high frequencies. Furthermore, ICRF-193 synergistically enhanced the yield of UVB-induced chromatid-type aberrations, chromatid exchanges in particular. Treated with ICRF-193 for the last 3 h before harvest, cells showed frequent incidence of chromatid-type aberrations and synergistic enhancement of UVB-induced chromatid-type aberrations, chromatid exchanges in particular. These results suggest that spontaneous and UVB-induced lesions might be ultimately transformed into chromatid-type aberrations by topoisomerase II-dependent checkpoint process(es) in the G(2) phase of the cell cycle. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码：35 / 38
页数：4
相关论文
共 50 条
  • [1] High yield of endoreduplication induced by ICRF-193:: a topoisomerase II catalytic inhibitor
    Pastor, N
    Flores, MJ
    Domínguez, I
    Mateos, S
    Cortés, F
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2002, 516 (1-2) : 113 - 120
  • [2] Topoisomerase II poisoning by ICRF-193
    Huang, KC
    Gao, HL
    Yamasaki, EF
    Grabowski, DR
    Liu, SJ
    Shen, LL
    Chan, KK
    Ganapathi, R
    Snapka, RM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (48) : 44488 - 44494
  • [3] Effects of ICRF-193, a catalytic inhibitor of DNA topoisomerase II, on sister chromatid exchange
    Hamatake, M
    Andoh, T
    Ishida, R
    ANTI-CANCER DRUGS, 1997, 8 (06) : 637 - 642
  • [4] Abnormal chromosome migration and chromosome aberrations in mouse oocytes during meiosis II in the presence of topoisomerase II inhibitor ICRF-193
    Tateno, H
    Kamiguchi, Y
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2002, 502 (1-2) : 1 - 9
  • [5] The SUMO pathway is required for selective degradation of DNA topoisomerase IIβ induced by a catalytic inhibitor ICRF-193
    Isik, S
    Sano, K
    Tsutsui, K
    Seki, M
    Enomoto, T
    Saitoh, H
    Tsutsui, K
    FEBS LETTERS, 2003, 546 (2-3): : 374 - 378
  • [6] The topoisomerase II catalytic inhibitor ICRF-193 preferentially targets telomeres that are capped by TRF2
    Chen, Lianxiang
    Zhu, Xiaowei
    Zou, Yaru
    Xing, Jun
    Gilson, Eric
    Lu, Yiming
    Ye, Jing
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2015, 308 (05): : C372 - C377
  • [7] DNA strand breaks induced by the anti-topoisomerase II bis-dioxopiperazine ICRF-193
    Hajji, N
    Pastor, N
    Mateos, S
    Domínguez, I
    Cortés, F
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2003, 530 (1-2) : 35 - 46
  • [8] Preparation of extended metaphase chromosomes from human cultured cells using a topoisomerase II inhibitor, ICRF-193
    Kohda, A
    Taguchi, H
    Okumura, K
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2001, 65 (05) : 1248 - 1251
  • [9] Chk1 is required for G2/M checkpoint response induced by the catalytic topoisomerase II inhibitor ICRF-193
    Robinson, Helen M. R.
    Bratlie-Thoresen, Sigrid
    Brown, Robert
    Gillespie, David A. F.
    CELL CYCLE, 2007, 6 (10) : 1265 - 1267
  • [10] PHOTOREACTIVATION OF ULTRAVIOLET-INDUCED CHROMOSOMAL-ABERRATIONS
    GRIGGS, HG
    BENDER, MA
    SCIENCE, 1973, 179 (4068) : 86 - 88
12345